Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression

To evaluate the anatomic site(s) of initial disease progression in patients with castration resistant metastatic prostate cancer (mCRPC) in the presence or absence of pre-treatment visceral metastases while on...

Source: Cancer Imaging - July 14, 2022 Category: Radiology Authors: Kathleen Ruchalski, Hyun J. Kim, Michael Douek, Steven Raman, Maitraya Patel, Victor Sai, Antonio Gutierrez, Benjamin Levine, Cheryce Fischer, Martin Allen-Auerbach, Pawan Gupta, Heidi Coy, Bianca Villegas, Matthew Brown and Jonathan Goldin Tags: Research article Source Type: research